| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/00365549509032724 |
| P698 | PubMed publication ID | 8658063 |
| P50 | author | Ola Weiland | Q42225632 |
| P2093 | author name string | Sönnerborg A | |
| Chen M | |||
| Wahl M | |||
| Mattsson L | |||
| Widell A | |||
| Norkrans G | |||
| Wejstål R | |||
| Lindh G | |||
| Schvarcz R | |||
| P2860 | cites work | Interferon for non-A, non-B chronic hepatitis | Q58803541 |
| Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources | Q29620774 | ||
| Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications | Q41015039 | ||
| Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants | Q41084008 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus | Q42987918 | ||
| Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in swedish blood donors | Q43038535 | ||
| Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. | Q43041128 | ||
| Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment | Q43041553 | ||
| Colorimetric detection of competitive PCR products for quantification of hepatitis C viremia | Q43042506 | ||
| Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease | Q43049022 | ||
| Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. | Q43049490 | ||
| Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection | Q45776314 | ||
| Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha | Q45789815 | ||
| P433 | issue | 4 | |
| P921 | main subject | chronic hepatitis C | Q55779873 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 319-324 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Infectious Diseases | Q7429961 |
| P1476 | title | Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection | |
| P478 | volume | 27 |
| Q43037154 | Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease |
| Q42631724 | Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study |
| Q42988935 | Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein |
| Q42993893 | Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon |
| Q33940500 | Methodological issues in papers on IFN therapy: time for reappraisal. |
| Q42989386 | Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification |
| Q33361949 | Successful long-term application of highly purified natural interferon-alpha (multiferon) after preceding interferon approaches in a chronic hepatitis C patient with thrombocytopenia |
Search more.